Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non Secreting Adenoma”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Very early researchUnknownNCT04489862
What this trial is testing

ΑPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors

Who this might be right for
Non-small-cell Lung CancerMesothelioma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 10
Very early researchStudy completedNCT05361083
What this trial is testing

First-in-human Evaluation of [18F]CETO

Who this might be right for
Primary Aldosteronism Due to Aldosterone Producing AdenomaPrimary Aldosteronism Due to Nodular HyperplasiaAdrenal Cushing Syndrome+2 more
Uppsala University 20
Not applicableLooking for participantsNCT07387419
What this trial is testing

Ultradian Steroid Rhythms in Adrenal Incidentalomas

Who this might be right for
Mild Autonomous Cortisol Secretion AdenomaNon Secreting Adenoma
University Hospital, Bordeaux 40
Early research (Phase 1)Study completedNCT00006368
What this trial is testing

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more
Novartis Pharmaceuticals 60
Not applicableStudy completedNCT06826170
What this trial is testing

Hypofractionated Radiosurgery to Treat Residual/Recurrent Non Secreting Pituitary Adenoma (HYPOADENO)

Who this might be right for
Pituitary NeoplasmsPituitary Adenoma
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 25
Not applicableStudy completedNCT06180226
What this trial is testing

Evaluation of Brain Functional Changes With 18F-FDG PET and Cognitive Processes After Brain Radiotherapy for Cavernous Sinus Meningiomas and Non-secreting ACTH Adenomas

Who this might be right for
Meningioma
IRCCS San Raffaele 20
Early research (Phase 1)Ended earlyNCT01088763
What this trial is testing

Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia

Who this might be right for
Childhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System ChoriocarcinomaChildhood Central Nervous System Germinoma+43 more
National Cancer Institute (NCI) 129
Testing effectiveness (Phase 2)Study completedNCT00001165
What this trial is testing

Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas

Who this might be right for
Islet Cell AdenomaNeoplasm MetastasisZollinger Ellison Syndrome
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 999
Not applicableLooking for participantsNCT05357456
What this trial is testing

Performances on Cognitive Functions and Brain Function and Follow-up After Different Treatments in Patients With Autonomous Cortisol Secretion: a Single-center, Prospective, Observational Study

Who this might be right for
Autonomous Cortisol SecretionAdrenal IncidentalomaNon-functioning Adrenal Adenomas
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 62
Not applicableStudy completedNCT06062082
What this trial is testing

Intraoperative Hemodynamic Instability During Unilateral Adrenalectomy for Pheochromocytoma

Who this might be right for
PheochromocytomaNon-Secretory Adrenal Adenoma
Central Hospital, Nancy, France 60
Testing effectiveness (Phase 2)Looking for participantsNCT06638931
What this trial is testing

Agnostic Therapy in Rare Solid Tumors

Who this might be right for
Urachal CancerParathyroid CarcinomaFibrolamellar Carcinoma+38 more
Instituto do Cancer do Estado de São Paulo 28